Ischemic Preconditioning in the Liver Is Independent of Regulatory T Cell Activity

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Devey, Luke R ^a   Richards, James A ^a   O'Connor, Richard A ^a   Borthwick, Gary ^a   Clay, Spike ^a   Howie, A Forbes ^a   Wigmore, Stephen J ^a   Anderton, Stephen M ^a   Howie, Sarah E M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL COUNT; CELL EXPANSION; CELL FUNCTION; CELL MOTILITY; CELL PROTECTION; CIRCULATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME REGULATION; IMMUNOMODULATION; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LIVER ISCHEMIA; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; REPERFUSION INJURY; T CELL DEPLETION;

ANIMALS; CHEMOKINES; CYTOKINES; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; INTERLEUKIN-2; ISCHEMIC PRECONDITIONING; LIVER; MICE; MICE, INBRED C57BL; REPERFUSION INJURY; SPLEEN; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 84869793873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049647     Document Type: Article

References (36)

1. Devey LR, Friend PJ, Forsythe JL, Mumford LL, Wigmore SJ, (2007) The use of marginal heart beating donor livers for transplantation in the United kingdom. Transplantation 84: 70-74.
2. Clavien PA, Yadav S, Sindram D, Bentley RC, (2000) Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Annals of surgery 232: 155-162.
3. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, et al. (2006) A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Annals of surgery 244: 921-928; discussion 928-930.
4. Caldwell CC, Okaya T, Martignoni A, Husted T, Schuster R, et al. (2005) Divergent functions of CD4+T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion. American journal of physiology Gastrointestinal and liver physiology 289: G969-976.
5. Lai LW, Yong KC, Igarashi S, Lien YH, (2007) A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney international 71: 1223-1231.
6. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RB, et al. (2001) Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. The Journal of clinical investigation 108: 1283-1290.
7. Burne-Taney MJ, Liu M, Baldwin WM, Racusen L, Rabb H, (2006) Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. Journal of immunology 176: 7015-7020.
8. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, et al. (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. Journal of the American Society of Nephrology: JASN 20: 1744-1753.
9. Horie Y, Wolf R, Chervenak RP, Jennings SR, Granger DN, (1999) T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia-reperfusion. Microcirculation 6: 267-280.
10. Savransky V, Molls RR, Burne-Taney M, Chien CC, Racusen L, et al. (2006) Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney international 69: 233-238.
11. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, et al. (1997) CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. The Journal of clinical investigation 100: 279-289.
12. Anselmo DM, Amersi FF, Shen XD, Gao F, Katori M, et al. (2002) FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2: 843-849.
13. Lien YH, Yong KC, Cho C, Igarashi S, Lai LW, (2006) S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney international 69: 1601-1608.
14. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD, (2010) Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney international 77: 771-780.
15. Lai LW, Yong KC, Lien YH, (2012) Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney international 81: 983-992.
16. Feng M, Wang Q, Zhang F, Lu L, (2012) Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury. International immunopharmacology 12: 189-196.
17. Lu L, Li G, Rao J, Pu L, Yu Y, et al. (2009) In vitro induced CD4(+)CD25(+)Foxp3(+) Tregs attenuate hepatic ischemia-reperfusion injury. International immunopharmacology 9: 549-552.
18. Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J, et al. (2004) Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39: 688-698.
19. Linden J, (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annual review of pharmacology and toxicology 41: 775-787.
20. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of experimental medicine 204: 1257-1265.
21. Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, et al. (2009) CD39+Foxp3+regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. Journal of immunology 183: 7602-7610.
22. Hart ML, Gorzolla IC, Schittenhelm J, Robson SC, Eltzschig HK, (2010) SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. Journal of immunology 184: 4017-4024.
23. Devey L, Ferenbach D, Mohr E, Sangster K, Bellamy CO, et al. (2009) Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol Ther 17: 65-72.
24. George JF, Braun A, Brusko TM, Joseph R, Bolisetty S, et al. (2008) Suppression by CD4+CD25+regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. The American journal of pathology 173: 154-160.
25. Suffner J, Hochweller K, Kuhnle MC, Li X, Kroczek RA, et al. (2010) Dendritic cells support homeostatic expansion of Foxp3+regulatory T cells in Foxp3.LuciDTR mice. Journal of immunology 184: 1810-1820.
26. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
27. Devey L, Festing MF, Wigmore SJ, (2008) Effect of temperature control upon a mouse model of partial hepatic ischaemia/reperfusion injury. Lab Anim 42: 12-18.
28. Devey L, Mohr E, Bellamy C, Simpson K, Henderson N, et al. (2009) c-Jun terminal kinase-2 gene deleted mice overexpress hemeoxygenase-1 and are protected from hepatic ischemia reperfusion injury. Transplantation 88: 308-316.
29. Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, et al. (2009) In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. The Journal of experimental medicine 206: 751-760.
30. O'Connor RA, Leech MD, Suffner J, Hammerling GJ, Anderton SM, (2010) Myelin-reactive, TGF-beta-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. Journal of immunology 185: 7235-7243.
31. Stephens LA, Malpass KH, Anderton SM, (2009) Curing CNS autoimmune disease with myelin-reactive Foxp3+Treg. European journal of immunology 39: 1108-1117.
32. Leech MD, Benson RA, De Vries A, Fitch PM, Howie SE, (2007) Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+regulatory cells. Journal of immunology 179: 7050-7058.
33. Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, et al. (2012) Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36: 717-730.
34. Wilson MS, Pesce JT, Ramalingam TR, Thompson RW, Cheever A, et al. (2008) Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. Journal of immunology 181: 6942-6954.
35. Monteiro RM, Camara NO, Rodrigues MM, Tzelepis F, Damiao MJ, et al. (2009) A role for regulatory T cells in renal acute kidney injury. Transplant immunology 21: 50-55.
36. Kuboki S, Sakai N, Tschop J, Edwards MJ, Lentsch AB, et al. (2009) Distinct contributions of CD4+T cell subsets in hepatic ischemia/reperfusion injury. American journal of physiology Gastrointestinal and liver physiology 296: G1054-1059.